SEC Form 4
SELLAS Life Sciences Group, Inc. (SLS) insider trading
In the 12 months to Nov 21, 2026, one SLS insider reported open-market purchases of $100.8K across 1 filing; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $100.8K
- 1 filing · Katherine Bach Kalin, Director
Who traded SLS, and when
- Purchase
SLS daily close from Nov 21, 2025 to Nov 20, 2026, between $1.39 and $19.15, last $13.66. 0 sale and 1 purchase filings by 1 insider, marked at their filing dates. Katherine Bach Kalin, Director: bought $100.8K across 1 filing, first filed Nov 21, 2025, last Nov 21, 2025.
Largest mark · tap a row for others
Katherine Bach Kalin · Director
Purchase $100,806
63,400 shares at $1.59 avg
Filed Nov 21, 2025 · traded Nov 19
Close on filing date $1.53
Katherine Bach Kalin · Director
Director
$100.8K boughtOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Katherine Bach Kalin | Director | — | $100.8K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Katherine Bach Kalin Director | Purchase | 63,400 | $1.59 | $100.8K | 104,400 |
GET /stocks/filings/vX/form-4?tickers=SLS&filing_date.gte=2025-11-21&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"SLS"
],
"issuer_cik": "0001390478",
"owner_cik": "0001832671",
"accession_number": "0001104659-25-114806",
"form_type": "4",
"filing_date": "2025-11-21",
"period_of_report": "2025-11-19",
"issuer_name": "SELLAS Life Sciences Group, Inc.",
"issuer_trading_symbol": "SLS",
"owner_name": "Kalin Katherine Bach",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2025-11-19",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 63400,
"transaction_price_per_share": 1.59,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 104400,
"transaction_value": 100806,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reflects the weighted average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $1.555 to $1.625 per share. Ms. Kalin undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price."
}
]
}
]
}
// trimmed to 1 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 14 records
- Tax withholding (sold to cover)3 records
- Grants and awards8 records
- Other3 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has SELLAS Life Sciences Group, Inc.'s CEO sold stock?
No. Angelos M. Stergiou (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is SLS’s insider data?
These are SLS Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track SLS insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for SLS every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.